TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 72 filers reported holding TRINITY BIOTECH PLC in Q4 2016. The put-call ratio across all filers is 55.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -99.1% | 125 | -99.4% | 0.00% | – |
| Q2 2016 | $227,000 | -3.4% | 20,125 | 0.0% | 0.00% | – |
| Q1 2016 | $235,000 | -0.8% | 20,125 | 0.0% | 0.00% | – |
| Q4 2015 | $237,000 | -6.0% | 20,125 | -9.0% | 0.00% | – |
| Q3 2015 | $252,000 | -30.8% | 22,125 | +9.9% | 0.00% | – |
| Q2 2015 | $364,000 | -6.2% | 20,125 | 0.0% | 0.00% | – |
| Q1 2015 | $388,000 | +10.9% | 20,125 | +0.6% | 0.00% | – |
| Q4 2014 | $350,000 | -4.4% | 20,000 | 0.0% | 0.00% | – |
| Q3 2014 | $366,000 | -56.6% | 20,000 | -45.5% | 0.00% | -100.0% |
| Q2 2014 | $844,000 | -4.8% | 36,686 | +0.1% | 0.00% | 0.0% |
| Q1 2014 | $887,000 | +76.7% | 36,638 | +83.2% | 0.00% | 0.0% |
| Q4 2013 | $502,000 | +15.1% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $436,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 672,100 | $14,625,000 | 5.62% |
| GOLDMAN CAPITAL MANAGEMENT INC | 312,000 | $6,789,000 | 4.48% |
| Lyon Street Capital, LLC | 407,586 | $8,870,047,000 | 4.37% |
| GREAT POINT PARTNERS LLC | 189,071 | $4,114,000 | 2.85% |
| Adirondack Research & Management Inc. | 161,507 | $3,514,000 | 2.02% |
| Park West Asset Management LLC | 483,355 | $10,518,000 | 1.56% |
| Benchmark Capital Advisors | 56,954 | $1,239,000 | 0.89% |
| WOODMONT INVESTMENT COUNSEL LLC | 76,607 | $1,667,000 | 0.61% |
| SHEPHERD KAPLAN KROCHUK, LLC | 156,000 | $3,394,000 | 0.55% |
| HEARTLAND ADVISORS INC | 1,250,364 | $27,208,000 | 0.50% |